Department Overview The mission of the Doernbecher Childhood Cancer Research Program is to advance the science and delivery of pediatric cancer care through a diverse portfolio of clinical trial opportunities, quality research, and collaboration. We are dedicated to finding and refining treatments to improve outcomes and quality of life from diagnosis through survivorship. OHSU Doernbecher's division of Pediatric Hematology/Oncology (PHO) treats about 150 newly diagnosed cancer patients a year, with several hundred patients on active treatment and in follow‐up. As a part of the Knight Cancer Institute and an active member of several consortia, including the Children's Oncology Group (COG) and Treatment Advances in Childhood Leukemia and Lymphoma (TACL), many of these patients are given the opportunity to participate in clinical trials. Join us in Making Childhood Cancer Extinct. The mission of the Knight Clinical Research Management (CRM) organization is to support the cond...